Fluralaner Powder For Inj Susp
83 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
83
Total Reports
4
Deaths Reported
480.0%
Death Rate
Active Ingredients
Fluralaner Powder For Inj Susp
Administration Routes
SubcutaneousUnknownOtherTopical
Species Affected
Dog 80
Human 3
Most Affected Breeds
Crossbred Canine/dog 29
Unknown 6
Bulldog - French 5
Dachshund - Miniature 3
Chihuahua 3
Spitz - German Pomeranian 3
Retriever - Labrador 3
Pug 2
Spaniel - King Charles 2
Retriever - Chesapeake Bay 2
Most Reported Reactions
Lack of efficacy (ectoparasite) - flea 19
Emesis (multiple) 17
Lethargy (see also Central nervous system depression in Neurological) 15
Hypersensitivity reaction 12
Facial swelling (see also Skin) 9
Diarrhoea 8
Fever 8
Hives (see also Skin) 7
Panting 7
Not himself/herself 5
Decreased appetite 4
Death 4
Outcome Breakdown
Ongoing
50 (60.2%)
Recovered/Normal
21 (25.3%)
Outcome Unknown
8 (9.6%)
Died
4 (4.8%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.